Cancer patients in India are facing a shortage of two common chemotherapy drugs. Platinum is a key ingredient in the treatments, but soaring prices are forcing manufacturers to cut production. Al Jazeera’s Minelle Fernandez reports. https://t.co/ojHIYhvbp2